GRIN2B

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
XentuzumabBI-836845Phase 2 ClinicalC.H. Boehringer Sohn Ag & Co. KgNeoplasms; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
DusigitumabMEDI-573Phase 2 ClinicalMedimmune LlcSolid tumours; Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular
Details
  • Product Inquiry
  • Clinical Drug Information
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호